Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Omontys, peginesatide (formerly Hematide)
print preview
bookmark
share with colleague
General Information
Company
Affymax Inc.
Description
Synthetic peptide-based erythropoiesis-stimulating agent (ESA)
Molecular Target
Erythropoietin (EPO) receptor
Mechanism of Action
Erythropoietin (EPO) receptor agonist
Latest Stage of Development
Marketed
Indication
Anemia
Partner
Nektar Therapeutics
;
Takeda Pharmaceutical Co. Ltd.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information